Activist 13D/13G Filings - Theseus Pharmaceuticals Inc. (THRX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-16
4:00 pm
Sale
13DTheseus Pharmaceuticals Inc.
THRX
TANG CAPITAL PARTNERS LP100
100.000%
-3,254,926decrease
(-100.00%)
View
2024-02-13
12:36 pm
Sale
13GTheseus Pharmaceuticals Inc.
THRX
Frazier Life Sciences Public Fund L.P.0
0.000%
-2,248,194decrease
(Position Closed)
View
2024-01-12
06:02 am
Unchanged
13DTheseus Pharmaceuticals Inc.
THRX
TANG CAPITAL PARTNERS LP3,255,026
7.300%
0
(Unchanged)
View
2023-12-28
06:00 am
Purchase
13DTheseus Pharmaceuticals Inc.
THRX
TANG CAPITAL PARTNERS LP3,255,026
7.300%
153,420increase
(+4.95%)
View
2023-12-27
4:43 pm
Unchanged
13DTheseus Pharmaceuticals Inc.
THRX
ORBIMED ADVISORS LLC17,713,600
40.100%
0
(Unchanged)
View
2023-11-24
4:28 pm
Unchanged
13DTheseus Pharmaceuticals Inc.
THRX
ORBIMED ADVISORS LLC17,713,600
40.100%
0
(Unchanged)
View
2023-11-24
4:23 pm
Unchanged
13DTheseus Pharmaceuticals Inc.
THRX
Foresite Capital Fund V L.P.5,494,621
12.400%
0
(Unchanged)
View
2023-11-24
1:49 pm
Purchase
13DTheseus Pharmaceuticals Inc.
THRX
TANG CAPITAL PARTNERS LP3,101,606
7.000%
3,101,606increase
(New Position)
View
2023-08-10
08:19 am
Sale
13GTheseus Pharmaceuticals Inc.
THRX
FMR LLC1,194
0.002%
-2,497,161decrease
(-99.95%)
View
2023-07-19
4:12 pm
Purchase
13DTheseus Pharmaceuticals Inc.
THRX
ORBIMED ADVISORS LLC17,713,600
40.700%
479,932increase
(+2.78%)
View
2023-07-19
2:41 pm
Purchase
13DTheseus Pharmaceuticals Inc.
THRX
Foresite Capital Fund V L.P.5,494,621
12.600%
700,000increase
(+14.60%)
View
2023-03-14
4:19 pm
Purchase
13DTheseus Pharmaceuticals Inc.
THRX
ORBIMED ADVISORS LLC17,233,668
39.600%
395,000increase
(+2.35%)
View
2023-02-09
12:39 pm
Sale
13GTheseus Pharmaceuticals Inc.
THRX
FMR LLC2,498,355
6.453%
-694,308decrease
(-21.75%)
View
2023-01-23
12:17 pm
Purchase
13GTheseus Pharmaceuticals Inc.
THRX
Frazier Life Sciences Public Fund L.P.2,248,194
5.800%
2,248,194increase
(New Position)
View
2023-01-03
4:36 pm
Purchase
13DTheseus Pharmaceuticals Inc.
THRX
Foresite Capital Fund V L.P.4,794,621
12.400%
500,000increase
(+11.64%)
View
2022-12-12
08:41 am
Sale
13GTheseus Pharmaceuticals Inc.
THRX
FMR LLC3,192,663
8.246%
-2,256,006decrease
(-41.40%)
View
2022-06-13
4:24 pm
Purchase
13DTheseus Pharmaceuticals Inc.
THRX
Foresite Capital Fund V L.P.4,294,621
11.100%
613,069increase
(+16.65%)
View
2022-02-09
10:01 am
Purchase
13GTheseus Pharmaceuticals Inc.
THRX
FMR LLC5,448,669
14.078%
1,494,953increase
(+37.81%)
View
2021-11-18
5:10 pm
Unchanged
13DTheseus Pharmaceuticals Inc.
THRX
ORBIMED ADVISORS LLC16,838,668
43.500%
0
(Unchanged)
View
2021-11-10
12:24 pm
Purchase
13GTheseus Pharmaceuticals Inc.
THRX
FMR LLC3,953,716
10.534%
3,953,716increase
(New Position)
View
Goto 0, 1, Next